Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 27,733 | 31,011 | 78,596 | 72,060 |
| Depreciation Amortization | N/A | 120,090 | 116,048 | 110,818 | 104,660 |
| Income taxes - deferred | N/A | 1,369 | 4,208 | 4,499 | -6,749 |
| Accounts receivable | N/A | 10,999 | 3,065 | -11,708 | -4,248 |
| Other Working Capital | N/A | 83,470 | 73,324 | -14,915 | -13,681 |
| Other Operating Activity | 0 | 33,355 | 26,341 | 12,480 | 3,150 |
| Operating Cash Flow | $N/A | $277,016 | $253,997 | $179,770 | $155,192 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -24,478 | -34,419 | N/A | N/A |
| PPE Investments | N/A | -118,153 | -237,119 | -674,402 | -366,662 |
| Other Investing Activity | 0 | 108,663 | 123,093 | 11,059 | -45,089 |
| Investing Cash Flow | $N/A | $-33,968 | $-148,445 | $-663,343 | $-411,751 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,186,537 | 705,045 | 1,605,564 | 704,340 |
| Debt Repayment | N/A | -1,349,918 | -631,875 | -1,143,908 | -522,486 |
| Common Stock Issued | N/A | 4,163 | 1,285 | 103,457 | 28,173 |
| Common Stock Repurchased | N/A | -7,946 | -34,118 | -40,869 | N/A |
| Dividend Paid | N/A | -17,706 | -8,829 | -3,260 | N/A |
| Other Financing Activity | 0 | -65,012 | -139,987 | -8,634 | 41,195 |
| Financing Cash Flow | $N/A | $-249,882 | $-108,479 | $512,350 | $251,222 |
| Exchange Rate Effect | N/A | 97 | 183 | -3 | 220 |
| Beginning Cash Position | N/A | 73,239 | 75,983 | 47,209 | 52,326 |
| End Cash Position | N/A | 66,502 | 73,239 | 75,983 | 47,209 |
| Net Cash Flow | $N/A | $-6,737 | $-2,744 | $28,774 | $-5,117 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 277,016 | 253,997 | 179,770 | 155,192 |
| Capital Expenditure | N/A | -219,450 | -318,811 | -740,004 | -432,336 |
| Free Cash Flow | 0 | 57,566 | -64,814 | -560,234 | -277,144 |